Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

Author: Schuster Michael  

Publisher: Springer Publishing Company

ISSN: 0941-4355

Source: Supportive Care in Cancer, Vol.16, Iss.5, 2008-05, pp. : 477-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content